This marks the first dedicated transcatheter heart valve approved for high-risk patients with severe, symptomatic AR.

Transit Officer Paul DeGeorge thought his son was lying on him. Then he realized something much scarier was happening.

A patient in the United States has become the first in the country to receive Corcym's next-generation Perceval Plus(R) LANCELOT sutureless aortic valve, marking an important milestone in the ...

JenaValve announced today that it has received FDA premarket approval (PMA) for its Trilogy transcatheter heart valve system.

Background Transcatheter aortic valve replacement (TAVR) has already been recommended for some high-risk patients with aortic ...

This breakthrough, which is a first in the Triad, offers a new option for patients with severe tricuspid regurgitation, a ...

Even women who felt well before pregnancy may begin to notice symptoms around 28 to 30 weeks, when the cardiovascular system reaches its peak workload.

JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that the U.S. Food and Drug Administration (FDA) has granted premarket ...

Conditions of the heart often develops silently over time, refusing attention until they begin to impact everyday life. One of such conditions is a Leaky Heart Valve or heart valve regurgitation, ...

Heart valves allow blood to flow one way and prevent it from flowing in the wrong direction. The tricuspid valve controls blood flow between the right atrium and right ventricle. The bicuspid or ...

No one was more surprised than Dr. Rick Dearman when he was diagnosed with severe symptomatic aortic stenosis, also known as heart valve failure. As a heart surgeon, he’d treated hundreds of people ...